All statistics and clinical interpretations are sourced from published Phase 2 and Phase 3 trial results as of October 2025
TL;DR GLP-1 drugs such as semaglutide, tirzepatide, and liraglutide can help reduce appetite and body weight, but emerging research shows they may also increase the risk of protein, vitamin, and mineral deficiencies, especially when appetite drops sharply and food intake becomes too low or too limited
Why Does My Tirzepatide Injection Site Itch
The transition is not always smooth
If side effects are severe or persistent, consult a healthcare provider
These lifestyle changes, along with the support of healthcare professionals, help optimize the effectiveness of the treatment and promote sustainable weight loss over time